Yamashita et al. reported that the destruction of β-catenin or inhibition of Tcf/ β-catenin complex formation decreased EpCAM expression in normal human hepatocytes and HCC cell lines [30]. This evidence concerns the gene EPCAM and hepatocellular carcinoma.